Effexor XR (venlafaxine hydrochloride) NDC 58151-125

NDC codes

FDA NDC Directory

Product NDC (as listed)58151-125Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58151-0125Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
58151-125-77	58151012577	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-125-77)Marketed from Jul 17, 2024
58151-125-93	58151012593	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-125-93)Marketed from Jul 17, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Effexor XRSuffix: XR
Generic name (nonproprietary): venlafaxine hydrochloride
Active ingredients: Venlafaxine hydrochloride — 37.5 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Viatris Specialty LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020699
Marketing start: Jul 17, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 58151-125_2319042f-5d24-42d3-9b0a-8893bed66813SPL ID 2319042f-5d24-42d3-9b0a-8893bed66813SPL set ID c848a5d8-ba94-4c84-80e3-0bf35fb8e32eRxCUI 313581, 313583, 313585, 729929, 729931, 729932UNII 7D7RX5A8MOUPC 0358151126934, 0358151125937, 0358151127931
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N458151012577 followed by a unit qualifier and the quantity

Package 58151-0125-77. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 15, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Effexor XR is indicated in adults for the treatment of: • Major Depressive Disorder (MDD) [see Clinical Studies (14.1) ] • Generalized Anxiety Disorder (GAD) [see Clinical Studies (14.2) ] • Social Anxiety Disorder (SAD) [see Clinical Studies (14.3) ] • Panic Disorder (PD) [see Clinical Studies (14.4) ] Effexor XR is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: • Major Depressive Disorder (MDD) ( 1 ) • Generalized Anxiety Disorder (GAD) ( 1 ) • Social Anxiety Disorder (SAD) ( 1 ) • Panic Disorder (PD) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020699

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020699
Product	Strength	Form · route	Labeler	Product NDC
Effexor XRvenlafaxine hydrochloride	Venlafaxine hydrochloride 75 mg/1	Capsule, Extended releaseOral	Viatris Specialty LLC	58151-126
Effexor XRvenlafaxine hydrochloride	Venlafaxine hydrochloride 150 mg/1	Capsule, Extended releaseOral	Viatris Specialty LLC	58151-127